BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 26608159)

  • 1. Disease Stage and Mode of Therapy Are Important Determinants of Treatment Outcomes for Medication-Related Osteonecrosis of the Jaw.
    Ruggiero SL; Kohn N
    J Oral Maxillofac Surg; 2015 Dec; 73(12 Suppl):S94-S100. PubMed ID: 26608159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical Therapy for Bisphosphonate-Related Osteonecrosis of the Jaw: Six-Year Experience of a Single Institution.
    Lopes RN; Rabelo GD; Rocha AC; Carvalho PA; Alves FA
    J Oral Maxillofac Surg; 2015 Jul; 73(7):1288-95. PubMed ID: 25871903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term success of surgery in bisphosphonate-related osteonecrosis of the jaws (BRONJs).
    Holzinger D; Seemann R; Klug C; Ewers R; Millesi G; Baumann A; Wutzl A
    Oral Oncol; 2013 Jan; 49(1):66-70. PubMed ID: 22892237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pedicled buccal fat pad flap as a reliable surgical strategy for the treatment of medication-related osteonecrosis of the jaw.
    Rotaru H; Kim MK; Kim SG; Park YW
    J Oral Maxillofac Surg; 2015 Mar; 73(3):437-42. PubMed ID: 25544302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.
    Ghidini G; Manfredi M; Giovannacci I; Mergoni G; Sarraj A; Mureddu M; Giunta G; Bonanini M; Meleti M; Vescovi P
    Minerva Stomatol; 2017 Aug; 66(4):135-140. PubMed ID: 28497661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is the role of hyperbaric oxygen in the management of bisphosphonate-related osteonecrosis of the jaw: a randomized controlled trial of hyperbaric oxygen as an adjunct to surgery and antibiotics.
    Freiberger JJ; Padilla-Burgos R; McGraw T; Suliman HB; Kraft KH; Stolp BW; Moon RE; Piantadosi CA
    J Oral Maxillofac Surg; 2012 Jul; 70(7):1573-83. PubMed ID: 22698292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal correlation between bisphosphonate termination and symptom resolution in osteonecrosis of the jaw: a pooled case report analysis.
    Hinson AM; Siegel ER; Stack BC
    J Oral Maxillofac Surg; 2015 Jan; 73(1):53-62. PubMed ID: 25511956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conservative surgical treatment of medication related osteonecrosis of the jaw (MRONJ) lesions in patients affected by osteoporosis exposed to oral bisphosphonates: 24 months follow-up.
    Nisi M; Karapetsa D; Gennai S; Ramaglia L; Graziani F; Gabriele M
    J Craniomaxillofac Surg; 2018 Jul; 46(7):1153-1158. PubMed ID: 29802059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant aqueous ozone in the treatment of bisphosphonate induced necrosis of the jaws: report of two cases and long-term follow-up.
    Brozoski MA; Lemos CA; Da Graça Naclério-Homem M; Deboni MC
    Minerva Stomatol; 2014; 63(1-2):35-41. PubMed ID: 24487948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience with the treatment of bisphosphonate-related osteonecrosis of the jaw.
    Janovska Z; Mottl R; Slezak R
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Jun; 159(2):313-7. PubMed ID: 24108250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple myeloma vs. breast cancer patients with bisphosphonates-related osteonecrosis of the jaws: a comparative analysis of response to treatment and predictors of outcome.
    Fortuna G; Ruoppo E; Pollio A; Aria M; Adamo D; Leuci S; Orabona GD; Mignogna MD
    J Oral Pathol Med; 2012 Mar; 41(3):222-8. PubMed ID: 22092390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Osteonecrosis of the Jaw.
    Yamachika E; Matsubara M; Ikeda A; Matsumura T; Moritani N; Iida S
    J Craniofac Surg; 2015 Oct; 26(7):e575-7. PubMed ID: 26468825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical treatment of medication-related osteonecrosis of the upper jaw: Case series.
    Aljohani S; Troeltzsch M; Hafner S; Kaeppler G; Mast G; Otto S
    Oral Dis; 2019 Mar; 25(2):497-507. PubMed ID: 30325561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dramatic osteonecrosis of the jaw associated with oral bisphosphonates, periodontitis, and dental implant removal.
    Fernández Ayora A; Herion F; Rompen E; Reginster JY; Magremanne M; Lambert F
    J Clin Periodontol; 2015 Feb; 42(2):190-5. PubMed ID: 25327450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can Surgical Management Improve Resolution of Medication-Related Osteonecrosis of the Jaw at Early Stages? A Prospective Cohort Study.
    Giudice A; Barone S; Diodati F; Antonelli A; Nocini R; Cristofaro MG
    J Oral Maxillofac Surg; 2020 Nov; 78(11):1986-1999. PubMed ID: 32615096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leucocyte-rich and platelet-rich fibrin for the treatment of bisphosphonate-related osteonecrosis of the jaw: a prospective feasibility study.
    Kim JW; Kim SJ; Kim MR
    Br J Oral Maxillofac Surg; 2014 Nov; 52(9):854-9. PubMed ID: 25138613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical therapy for medication-related osteonecrosis of the jaw in osteoporotic patients treated with antiresorptive agents.
    Hauer L; Jambura J; Hrusak D; Chalupova M; Posta P; Rusnak S; Vyskocil V
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Mar; 164(1):100-107. PubMed ID: 30647474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of surgical outcome and influencing risk factors in patients with medication-related osteonecrosis of the jaws.
    Klingelhöffer C; Zeman F; Meier J; Reichert TE; Ettl T
    J Craniomaxillofac Surg; 2016 Oct; 44(10):1694-1699. PubMed ID: 27591091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does Fluorodeoxyglucose Positron Emission Tomography With Computed Tomography Facilitate Treatment of Medication-Related Osteonecrosis of the Jaw?
    Fleisher KE; Pham S; Raad RA; Friedman KP; Ghesani M; Chan KC; Amintavakoli N; Janal M; Levine JP; Glickman RS
    J Oral Maxillofac Surg; 2016 May; 74(5):945-58. PubMed ID: 26657395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the conservative non-surgical management of medication-related osteonecrosis of the jaw an appropriate treatment option for early stages? A long-term single-center cohort study.
    Ristow O; Rückschloß T; Müller M; Berger M; Kargus S; Pautke C; Engel M; Hoffmann J; Freudlsperger C
    J Craniomaxillofac Surg; 2019 Mar; 47(3):491-499. PubMed ID: 30642734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.